{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:45:11Z","timestamp":1790196311190,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.autrev.2021.102949","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T23:41:41Z","timestamp":1631230901000},"page":"102949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Unraveling the complexities of psoriatic arthritis by the use of -Omics and their relevance for clinical care"],"prefix":"10.1016","volume":"20","author":[{"given":"Alexandros","family":"Grivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Fragoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Garantziotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggelos","family":"Banos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Nikiphorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Boumpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2021.102949_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrg.2018.4","article-title":"Integrative omics for health and disease","author":"Karczewski","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.autrev.2021.102949_bb0010","doi-asserted-by":"crossref","DOI":"10.1177\/1352458519884249","article-title":"Lessons from precision medicine in rheumatology","author":"Wampler Muskardin","year":"2020","journal-title":"Mult Scler J"},{"key":"10.1016\/j.autrev.2021.102949_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.03.022","article-title":"Systems medicine in chronic inflammatory diseases","author":"Schultze","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2021.102949_bb0020","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.102949_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108519","article-title":"Psoriatic arthritis; overcoming the challenges by creating opportunities","author":"Bell","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2021.102949_bb0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.autrev.2018.11.007","article-title":"Amplifying the concept of psoriatic arthritis: the role of autoimmunity in systemic psoriatic disease","volume":"18","author":"Chimenti","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102949_bb0035","first-page":"210","article-title":"Psoriasis, psoriatic arthritis, or psoriatic disease?","volume":"33","author":"Scarpa","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/rmdopen-2018-000656","article-title":"Distinguishing rheumatoid arthritis from psoriatic arthritis","volume":"4","author":"Merola","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2021.102949_bb0045","first-page":"1340","article-title":"Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?","volume":"59","author":"Feld","year":"2020","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.autrev.2021.102949_bb0050","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-018-4012-7","article-title":"Psoriatic arthritis: tissue-directed inflammation?","author":"Cafaro","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41584-020-00507-9","article-title":"Applying precision medicine to unmet clinical needs in psoriatic disease","author":"Jadon","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2008.089367","article-title":"Familial aggregation of psoriatic arthritis","author":"Chandran","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kep243","article-title":"A strong heritability of psoriatic arthritis over four generations--the Reykjavik psoriatic arthritis study","author":"Karason","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2021.102949_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-017-0447-y","article-title":"Genome-wide association and targeted analysis of copy number variants with psoriatic arthritis in German patients","author":"Uebe","year":"2017","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.autrev.2021.102949_bb0075","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kev273","article-title":"Identifying a novel locus for psoriatic arthritis","author":"Budu-Aggrey","year":"2016","journal-title":"Rheumatol (U K)"},{"key":"10.1016\/j.autrev.2021.102949_bb0080","article-title":"Promise and pitfalls of the Immunochip","author":"Cortes","year":"2011","journal-title":"Arthrit Res Ther"},{"key":"10.1016\/j.autrev.2021.102949_bb0085","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.190119","article-title":"The genetics of psoriasis and psoriatic arthritis","author":"O\u2019Rielly","year":"2019","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.autrev.2021.102949_bb0090","article-title":"Using functional genomics to advance the understanding of psoriatic arthritis","author":"Shi","year":"2020","journal-title":"Revmatologiia (Bulgaria)"},{"key":"10.1016\/j.autrev.2021.102949_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-207187","article-title":"PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PSA-specific risk locus","author":"Bowes","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0100","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0000000000000136","article-title":"What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis?","author":"Eder","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2006.064972","article-title":"HLA-Cw6 and HLA-DRB1 *07 together are associated with less severe joint disease in psoriatic arthritis","author":"Ho","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/ar2097","article-title":"HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis","author":"Queiro","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2021.102949_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/art.33415","article-title":"HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype","author":"Winchester","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102949_bb0120","article-title":"Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis","author":"Bowes","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2013.07.014","article-title":"Human leukocyte antigen alleles and susceptibility to psoriatic arthritis","author":"Chandran","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2021.102949_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajhg.2014.07.002","article-title":"Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes","author":"Okada","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2021.102949_bb0135","article-title":"Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study","author":"Eder","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-205461","article-title":"Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype","author":"Haroon","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.rdc.2015.07.002","article-title":"Genetic, epigenetic and pharmacogenetic aspects of psoriasis and psoriatic arthritis","author":"O\u2019Rielly","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2021.102949_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-214158","article-title":"Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis","author":"Aterido","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0155","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1038\/ncomms7046","article-title":"Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis","volume":"6","author":"Bowes","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2021.102949_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2011.415","article-title":"Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL","author":"Ellinghaus","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/ng.688","article-title":"CoMon variants at TRAF3IP2 are aSociated with susceptibility to psoriatic arthritis and psoriasis","author":"H\u00fcffmeier","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2021.102949_bb0170","article-title":"A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci","author":"Liu","year":"2008","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.autrev.2021.102949_bb0175","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-\u03baB pathways","author":"Nair","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2021.102949_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/ng.693","article-title":"Genome-wide asociation analysis identifies three psoriasis susceptibility loci","author":"Stuart","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2021.102949_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture","author":"Stuart","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2021.102949_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-1078-x","article-title":"Capture hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23","author":"McGovern","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.autrev.2021.102949_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/art.39083","article-title":"Efficacy and safety of anti-interleukin-20 monoclonal antibody in patients with rheumatoid arthritis: a randomized phase IIa trial","author":"\u0160enolt","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134703","article-title":"First-in-human, phase 1, randomized, dose-escalation trial with recombinant anti-IL-20 monoclonal antibody in patients with psoriasis","author":"Gottlieb","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102949_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-207190","article-title":"A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk","author":"Juli\u00e0","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0210","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.091311","article-title":"Folate pathway enzyme gene polymorphisms and the efficacy and toxicity of methotrexate in psoriatic arthritis","author":"Chandran","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0215","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.110980","article-title":"FCGR2A\/CD32A and FCGR3A\/CD16A variants and EULAR response to tumor necrosis factor-\u03b1 blockers in psoriatic arthritis: a longitudinal study with 6 months of followup","author":"Ram\u00edrez","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2012.02.003","article-title":"Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis","author":"Morales-Lara","year":"2012","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.autrev.2021.102949_bb0225","doi-asserted-by":"crossref","DOI":"10.2217\/pgs.14.125","article-title":"PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis","author":"Juli\u00e0","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.autrev.2021.102949_bb0230","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kel175","article-title":"The \u2212308 tumour necrosis factor-\u03b1 gene polymorphism predicts therapeutic response to TNF\u03b1-blockers in rheumatoid arthritis and spondyloarthritis patients","author":"Seitz","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2021.102949_bb0235","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-015-0518-z","article-title":"Pharmacogenetics of treatment response in psoriatic arthritis","author":"Jani","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2021.102949_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2014.123","article-title":"TNF-\u03b1 gene polymorphisms: association with disease susceptibility and response to anti-TNF-\u03b1 treatment in psoriatic arthritis","author":"Murdaca","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/nrg2484","article-title":"RNA-Seq: a revolutionary tool for transcriptomics","author":"Wang","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.autrev.2021.102949_bb0250","doi-asserted-by":"crossref","DOI":"10.2119\/2006-00003.Gulko","article-title":"Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis","author":"Batliwalla","year":"2005","journal-title":"Mol Med"},{"key":"10.1016\/j.autrev.2021.102949_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/sj.gene.6364334","article-title":"A distinct inflammatory gene expression profile in patients with psoriatic arthritis","author":"Stoeckman","year":"2006","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2021.102949_bb0260","doi-asserted-by":"crossref","DOI":"10.1007\/s00439-002-0812-5","article-title":"Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees","author":"Semprini","year":"2002","journal-title":"Hum Genet"},{"key":"10.1016\/j.autrev.2021.102949_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/art.20631","article-title":"Proinflammatory S100 proteins in arthritis and autoimmune disease","author":"Foell","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102949_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128262","article-title":"Gene expression profiling in peripheral blood cells and synovial membranes of patients with psoriatic arthritis","author":"Dolcino","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102949_bb0275","doi-asserted-by":"crossref","DOI":"10.1007\/s40744-019-0159-1","article-title":"Psoriatic arthritis: what is happening at the joint?","author":"Belasco","year":"2019","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.autrev.2021.102949_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","author":"Schwartz","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2021.102949_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/art.38995","article-title":"Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis","author":"Belasco","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2014.414","article-title":"Gene expression differences between psoriasis patients with and without inflammatory arthritis","author":"Pollock","year":"2015","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0295","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-014-2807-8","article-title":"Distinct genetic profile in peripheral blood mononuclear cells of psoriatic arthritis patients treated with methotrexate and TNF-inhibitors","author":"Cuchacovich","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110657","article-title":"Divergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy","author":"Rosenberg","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102949_bb0305","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2015.10414","article-title":"Epigenetics at the crossroads of genes and the environment","author":"Feinberg","year":"2015","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.autrev.2021.102949_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2007.02.006","article-title":"Epigenetics: a landscape takes shape","author":"Goldberg","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102949_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/acr.22625","article-title":"Further evidence supporting a parent-of-origin effect in psoriatic disease","author":"Pollock","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2021.102949_bb0320","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-eular.3309","article-title":"AB0160 epigenetic studies in maternally versus paternally transmitted psoriatic disease","author":"O\u2019Rielly","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212043","article-title":"Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis","author":"Pollock","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102949_bb0330","series-title":"OP0203 characterizing the epigenomic landscape of psoriasis patients destined to develop psoriatic arthritis","author":"Pollock","year":"2019"},{"key":"10.1016\/j.autrev.2021.102949_bb0335","first-page":"113","article-title":"Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis","volume":"35","author":"Ciancio","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0340","series-title":"FRI0358 role of mirna-21-5PAS a potential biomarker for the inflammation pathway in psoriatic disease and response to methotrexate treatment","author":"Machhar","year":"2019"},{"key":"10.1016\/j.autrev.2021.102949_bb0345","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7305380","article-title":"MicroRNA expression profiling in psoriatic arthritis","author":"Pelosi","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2021.102949_bb0350","article-title":"MiR-146a-5p expression in peripheral CD14+ monocytes from patients with psoriatic arthritis induces osteoclast activation, bone Resorption, and correlates with clinical response","author":"Lin","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2021.102949_bb0355","article-title":"Upregulation of mir-941 in circulating cd14+ monocytes enhances osteoclast activation via wnt16 inhibition in patients with psoriatic arthritis","author":"Lin","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2021.102949_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2018.08.008","article-title":"Altered expression of microRNA-23a in psoriatic arthritis modulates synovial fibroblast pro-inflammatory mechanisms via phosphodiesterase 4B","author":"Wade","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.102949_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2018.00186","article-title":"Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features","author":"Alivernini","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2021.102949_bb0370","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.190602","article-title":"Serum microrna signature as a diagnostic and therapeutic marker in patients with psoriatic arthritis","author":"Wade","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0375","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-eular.3172","article-title":"OP0200 global DNA methylation patterns differ between responders and non-responders in psoriatic arthritis patients treated with tumor necrosis factor-\u03b1 inhibitors","author":"O\u2019Rielly","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0380","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-eular.2963","article-title":"AB0022 comparison of in vitro effects of kinase and epigenetic inhibitors on TH17 responses in inflammatory arthritis","author":"Hammitzsch","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0385","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1501956112","article-title":"CBP30, a selective CBP\/p300 bromodomain inhibitor, suppresses human Th17 responses","author":"Hammitzsch","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.102949_bb0390","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbw114","article-title":"Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences","author":"Manzoni","year":"2018","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.autrev.2021.102949_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes6010005","article-title":"Exploring the psoriatic arthritis proteome in search of novel biomarkers","author":"Mahendran","year":"2018","journal-title":"Proteomes"},{"key":"10.1016\/j.autrev.2021.102949_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2015.12.020","article-title":"IL-9, a local growth factor for synovial T cells in inflammatory arthritis","author":"Kundu-Raychaudhuri","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2021.102949_bb0405","doi-asserted-by":"crossref","DOI":"10.1111\/cei.12449","article-title":"Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation","author":"Scrivo","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102949_bb0410","doi-asserted-by":"crossref","DOI":"10.1186\/1559-0275-11-27","article-title":"Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry","author":"Cretu","year":"2014","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.autrev.2021.102949_bb0415","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/474028","article-title":"Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris","author":"Dalm\u00e1dy","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2021.102949_bb0420","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/art.39800","article-title":"Brief report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis","volume":"68","author":"Abji","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225617","article-title":"Differences in osteoimmunological biomarkers predictive of psoriatic arthritis among a large Italian cohort of psoriatic patients","author":"Diani","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2021.102949_bb0430","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/rheumatology\/keaa405","article-title":"Broad proteomic screen reveals shared serum proteomic signature in patients with psoriatic arthritis and psoriasis without arthritis","volume":"60","author":"Leijten","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2021.102949_bb0435","doi-asserted-by":"crossref","DOI":"10.1186\/1559-0275-12-1","article-title":"Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers","author":"Cretu","year":"2015","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.autrev.2021.102949_bb0440","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1417-7","article-title":"Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study","author":"Jadon","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2021.102949_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115424","article-title":"Crossreactive autoantibodies directed against cutaneous and joint antigens are present in psoriatic arthritis","author":"Dolcino","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102949_bb0450","doi-asserted-by":"crossref","DOI":"10.1038\/srep40473","article-title":"Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups","author":"Siebert","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2021.102949_bb0455","article-title":"Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placebo","author":"Tak","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102949_bb0460","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.121162","article-title":"Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis","author":"Chandran","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102949_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201500051","article-title":"A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-\u03b1 treatment of psoriatic arthritis","author":"Collins","year":"2016","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.autrev.2021.102949_bb0470","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-205417","article-title":"Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis","author":"Ademowo","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0475","doi-asserted-by":"crossref","DOI":"10.4062\/biomolther.2015.078","article-title":"Alpha-ketoglutarate: physiological functions and applications","author":"Wu","year":"2016","journal-title":"Biomol Therap"},{"key":"10.1016\/j.autrev.2021.102949_bb0480","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.4709.1","article-title":"Metabolomics in psoriatic disease: Pilot study reveals metabolite differences in psoriasis and psoriatic arthritis","author":"Armstrong","year":"2014","journal-title":"F1000Research"},{"key":"10.1016\/j.autrev.2021.102949_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2012.10.025","article-title":"High levels of very long-chain saturated fatty acid in erythrocytes correlates with atherogenic lipoprotein profiles in subjects with metabolic syndrome","author":"Matsumori","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.autrev.2021.102949_bb0490","doi-asserted-by":"crossref","DOI":"10.1186\/ar3243","article-title":"Diagnostic properties of metabolic perturbations in rheumatoid arthritis","author":"Madsen","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2021.102949_bb0495","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-216374","article-title":"Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis","author":"Souto-Carneiro","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102949_bb0500","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-019-1527-0","article-title":"Pro- and anti-inflammatory eicosanoids in psoriatic arthritis","author":"Coras","year":"2019","journal-title":"Metabolomics"},{"key":"10.1016\/j.autrev.2021.102949_bb0505","article-title":"Eicosanoid storm in infection and inflammation","author":"Dennis","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2021.102949_bb0510","article-title":"Urine metabolome profiling of immune-mediated inflammatory diseases","author":"Juli\u00e0","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2021.102949_bb0515","doi-asserted-by":"crossref","DOI":"10.1002\/art.37921","article-title":"Metabolic profiling predicts response to anti-tumor necrosis factor \u03b1 therapy in patients with rheumatoid arthritis","author":"Kapoor","year":"2013","journal-title":"Arthritis Rheum"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722100224X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722100224X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:22:12Z","timestamp":1761600132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899722100224X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":103,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S156899722100224X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102949","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the complexities of psoriatic arthritis by the use of -Omics and their relevance for clinical care","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102949"}}